ORCL
65
-2
CINF
53
2
EOG
58
2
URBN
56
14
M
37
12
PPL
54
-5
FE
50
-2
BK
74
2
GOOG
50
-3
ADSK
70
2
AA
48
-12
R
71
4
LH
43
-2
PG
56
5
EL
25
4
JWN
48
6
SO
53
-4
EXC
53
-3
LMT
34
2
TROW
56
5
ORCL
65
-2
CINF
53
2
EOG
58
2
URBN
56
14
M
37
12
PPL
54
-5
FE
50
-2
BK
74
2
GOOG
50
-3
ADSK
70
2
AA
48
-12
R
71
4
LH
43
-2
PG
56
5
EL
25
4
JWN
48
6
SO
53
-4
EXC
53
-3
LMT
34
2
TROW
56
5
Financhill
Back

Halozyme Therapeutics Vs. Lexicon Pharmaceuticals Industry Stock Comparison

Buy
51

HALO
Halozyme Therapeutics

Last Price:
49.01
Seasonality Move:
17.34%
Sell
24

LXRX
Lexicon Pharmaceuticals

Last Price:
0.87
Seasonality Move:
18.61%
Buy
51
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $49.00. The Score for HALO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Lexicon Pharmaceuticals (LXRX) is a Sell

Is Lexicon Pharmaceuticals a Buy, Sell or Hold?

  • The current Lexicon Pharmaceuticals [LXRX] share price is $0.86. The Score for LXRX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • LXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $49.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

LXRX Stock Price Chart

What is Lexicon Pharmaceuticals's stock price today?

  • The Lexicon Pharmaceuticals share price today is $0.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.25 Sell
Relative Strength Index (14 RSI): 43.09 Sell
Chaikin Money Flow: 3002123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.05 - 58.35) Sell
Bollinger Bands (100): (51.29 - 60.61) Sell

LXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 28.27 Sell
Chaikin Money Flow: 6632719 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.95 - 1.81) Sell
Bollinger Bands (100): (1.34 - 2.02) Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.26 Buy
20-day SMA: 53.24 Sell
50-day SMA: 54.79 Sell
200-day SMA: 49.21 Sell
8-day EMA: 48.74 Buy
20-day EMA: 51.64 Sell
50-day EMA: 53.83 Sell
200-day EMA: 50.48 Sell

LXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.92 Sell
20-day SMA: 1.25 Sell
50-day SMA: 1.52 Sell
200-day SMA: 1.86 Sell
8-day EMA: 0.93 Sell
20-day EMA: 1.17 Sell
50-day EMA: 1.43 Sell
200-day EMA: 1.7 Sell

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.19 per share.

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lexicon Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):